small molecule modulator discovery

ADRx, Inc. is a drug discovery company with an innovative platform that transforms atomic structures into small molecule therapies to treat Alzheimer's, ALS, Parkinson's Disease, and more. It describes itself as the first company to successfully apply structure-based design to disrupt protein aggregation diseases, with the ability to identify, design and develop therapeutics to patient-derived pathological protein structures.

Read more

drug discoverystructure-based designtherapeutic design and development